Image
National News

RESTRICTED -- A Panel of FDA Advisers Is Meeting About Merck’s COVID Pill

An undated photo provided by Merck shows the company’s antiviral drug known as molnupiravir, the first in a new class of treatments that could work against a wide range of coronavirus variants. Health officials around the world have been counting on the new treatments to reduce the number of severe cases and save lives. (Merck via The New York Times) -- NO SALES; FOR EDITORIAL USE ONLY WITH NYT STORY SLUGGED VIRUS MERCK PILL BY REBECCA ROBBINS and CARL ZIMMER FOR NOV. 30, 2021. ALL OTHER USE PROHIBITED. --